Phil Lieberman

18.9k total citations · 2 hit papers
201 papers, 5.4k citations indexed

About

Phil Lieberman is a scholar working on Immunology and Allergy, Physiology and Surgery. According to data from OpenAlex, Phil Lieberman has authored 201 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Immunology and Allergy, 51 papers in Physiology and 41 papers in Surgery. Recurrent topics in Phil Lieberman's work include Food Allergy and Anaphylaxis Research (104 papers), Allergic Rhinitis and Sensitization (83 papers) and Asthma and respiratory diseases (50 papers). Phil Lieberman is often cited by papers focused on Food Allergy and Anaphylaxis Research (104 papers), Allergic Rhinitis and Sensitization (83 papers) and Asthma and respiratory diseases (50 papers). Phil Lieberman collaborates with scholars based in United States, Canada and United Kingdom. Phil Lieberman's co-authors include Scott H. Sicherer, F. Estelle R. Simons, Aziz Sheikh, Robert L. Siegle, Carlos A. Camargo, Kari Bohlke, Rachel L. Miller, Hershel Jick, Mirna Chehade and Jonathan A. Bernstein and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Phil Lieberman

191 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International consensus on (ICON) anaphylaxis

2014 310 citations F. Estelle R. Simons, Phil Lieberman et al. World Allergy Organization Journal profile →
Drug allergy: A 2022 practice parameter update

2022 246 citations David B.K. Golden, Matthew Greenhawt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phil Lieberman United States	41	3.6k	1.7k	1.1k	924	909	201	5.4k
Dana Wallace United States	24	3.5k 1.0×	2.2k 1.3×	1.6k 1.5×	663 0.7×	409 0.4×	53	4.8k
Gianenrico Senna Italy	40	4.2k 1.2×	2.9k 1.7×	1.6k 1.5×	1.2k 1.3×	658 0.7×	279	6.8k
Dennis K. Ledford United States	31	2.0k 0.5×	1.4k 0.8×	712 0.7×	785 0.8×	434 0.5×	116	3.9k
Stephen A. Tilles United States	27	2.3k 0.6×	1.8k 1.1×	1.2k 1.1×	323 0.3×	373 0.4×	89	4.2k
John Oppenheimer United States	35	3.3k 0.9×	2.9k 1.7×	1.5k 1.4×	506 0.5×	410 0.5×	136	5.4k
F. Estelle R. Simons Canada	31	2.4k 0.6×	1.7k 1.0×	710 0.7×	611 0.7×	393 0.4×	68	3.7k
N. Franklin Adkinson United States	46	3.7k 1.0×	3.6k 2.1×	1.6k 1.5×	2.3k 2.5×	435 0.5×	165	8.2k
Pamela Ewan United Kingdom	39	3.4k 0.9×	1.3k 0.8×	1.4k 1.4×	748 0.8×	760 0.8×	104	5.1k
Victòria Cardona Spain	30	2.9k 0.8×	1.1k 0.6×	981 0.9×	809 0.9×	602 0.7×	109	4.0k
Mario Sánchez‐Borges Venezuela	37	3.7k 1.0×	1.8k 1.1×	1.9k 1.8×	2.7k 2.9×	565 0.6×	134	7.2k

Countries citing papers authored by Phil Lieberman

Since Specialization

Citations

This map shows the geographic impact of Phil Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Lieberman more than expected).

Fields of papers citing papers by Phil Lieberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Lieberman. The network helps show where Phil Lieberman may publish in the future.

Co-authorship network of co-authors of Phil Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Lieberman. A scholar is included among the top collaborators of Phil Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Lieberman. Phil Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anagnostou, Aikaterini, Elissa M. Abrams, William Anderson, et al.. (2025). Development of a validated, updated North American pediatric food allergy anaphylaxis management plan. Annals of Allergy Asthma & Immunology. 135(1). 71–78.e4.

Anagnostou, Aikaterini, Matthew Greenhawt, Phil Lieberman, et al.. (2024). Management of children with food allergies by allergists in the United States. SHILAP Revista de lepidopterología. 4(1). 100379–100379. 1 indexed citations

Anagnostou, Aikaterini, Elissa M. Abrams, Edmond S. Chan, et al.. (2024). Development and acceptability of a decision‐aid for food allergy oral immunotherapy in children. Allergy. 80(1). 205–214. 5 indexed citations

Carr, Warner, Carla M. Davis, David M. Fleischer, et al.. (2023). Immune response evolution in peanut epicutaneous immunotherapy forpeanut‐allergicchildren. Allergy. 78(9). 2467–2476. 7 indexed citations

Anagnostou, Aikaterini, Phil Lieberman, Matthew Greenhawt, et al.. (2023). The future of food allergy: Challenging existing paradigms of clinical practice. Allergy. 78(7). 1847–1865. 15 indexed citations

Ochoa, Sebastian, Michael S. Abers, Lindsey B. Rosen, et al.. (2023). Management and outcome of COVID-19 in CTLA-4 insufficiency. Blood Advances. 7(19). 5743–5751. 3 indexed citations

Lieberman, Phil, et al.. (2023). Update on clinical research for food allergy treatment. SHILAP Revista de lepidopterología. 4. 1154541–1154541. 4 indexed citations

Lieberman, Phil, et al.. (2019). Who needs to carry an epinephrine autoinjector?. Cleveland Clinic Journal of Medicine. 86(1). 66–72. 6 indexed citations

Lieberman, Phil, et al.. (2018). A randomized, double-blinded, placebo-controlled study of the use of viscous oral cromolyn sodium for the treatment of eosinophilic esophagitis. Annals of Allergy Asthma & Immunology. 120(5). 527–531. 27 indexed citations

10.

Carter, Melody C., et al.. (2017). Identification of alpha‐gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis. Allergy. 73(5). 1131–1134. 49 indexed citations

11.

Lieberman, Phil, et al.. (2012). Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy. 67(10). 1299–1307. 79 indexed citations

12.

Bousquet, Jean, Warner Carr, Jonine L. Bernstein, et al.. (2012). MP29-02 is effective for the symptomatic treatment of seasonal allergic rhinitis even in those with very severe disease: a meta-analysis. Allergy. 67. 336–336. 1 indexed citations

13.

Acaster, Sarah, Warner Carr, Phil Lieberman, Claus Bachert, & David Price. (2012). Treatment preferences in patients with moderate-severe seasonal allergic rhinitis: findings of a discrete choice experiment. Annals of Allergy Asthma & Immunology. 109. 7 indexed citations

14.

Lieberman, Phil, et al.. (2012). The Utility of Peanut Components in the Diagnosis of IgE-Mediated Peanut Allergy Among Distinct Populations. The Journal of Allergy and Clinical Immunology In Practice. 1(1). 75–82. 75 indexed citations

15.

Lieberman, Phil. (2009). The Role of Antihistamines in the Treatment of Vasomotor Rhinitis. World Allergy Organization Journal. 2(8). 156–161. 11 indexed citations

16.

Lieberman, Phil. (2008). Decline in Rotavirus Cases in the U.S. After Licensure of a Live, Oral Rotavirus Vaccine. 46th Annual Meeting. 2 indexed citations

17.

Lieberman, Phil, Carlos A. Camargo, Kari Bohlke, et al.. (2006). Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Annals of Allergy Asthma & Immunology. 97(5). 596–602. 342 indexed citations

18.

Lieberman, Phil. (2005). Biphasic anaphylactic reactions. Annals of Allergy Asthma & Immunology. 95(3). 217–226. 167 indexed citations

19.

Lieberman, Phil, et al.. (2000). Allergic Diseases. Humana Press eBooks. 1 indexed citations

20.

Patterson, Roy & Phil Lieberman. (1996). Idiopathic Anaphylaxis: A Purely Internal Reaction. Hospital Practice. 31(7). 47–66. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact